Cresset Asset Management, LLC Ensysce Biosciences, Inc. Transaction History

Cresset Asset Management, LLC

  • $20.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
N/A
-11,223 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
N/A
-2,494 Reduced 18.18%
11,223 $53,000
Q3 2021

Nov 15, 2021
BUY
N/A
13,717 New
13,717 $42,000

Others Institutions Holding ENSC

# of Institutions
2
Shares Held
120
Call Options Held
0
Put Options Held
0
View Full List

About Ensysce Biosciences, Inc.

ENSC Quotes by TradingView
  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $979K
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email